Advertisement
Review Article| Volume 49, ISSUE 11, P1177-1184, November 2017

Download started.

Ok

A consumer’s guide for probiotics: 10 golden rules for a correct use

  • Marco Toscano
    Affiliations
    Laboratory of Clinical Microbiology, Department of Biomedical Science for Health, University of Milan, Milan, Italy
    Search for articles by this author
  • Roberta De Grandi
    Affiliations
    Laboratory of Clinical Microbiology, Department of Biomedical Science for Health, University of Milan, Milan, Italy
    Search for articles by this author
  • Luca Pastorelli
    Affiliations
    Department of Biomedical Science for Health, University of Milan, Milan, Italy

    Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy
    Search for articles by this author
  • Maurizio Vecchi
    Affiliations
    Department of Biomedical Science for Health, University of Milan, Milan, Italy

    Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy
    Search for articles by this author
  • Lorenzo Drago
    Correspondence
    Corresponding author at: IRCCS Galeazzi Orthopaedic Institute, Milan, Italy.
    Affiliations
    Laboratory of Clinical Microbiology, Department of Biomedical Science for Health, University of Milan, Milan, Italy

    Laboratory of Clinical-Chemistry and Microbiology, IRCCS Galeazzi Institute, University of Milan, Milan, Italy
    Search for articles by this author
Published:August 01, 2017DOI:https://doi.org/10.1016/j.dld.2017.07.011

      Abstract

      Probiotics are used all over the world as their beneficial effects on the human organism have been widely demonstrated. Certain probiotics can down-regulate production of pro-inflammatory cytokines and promote intestinal epithelial barrier functions, increasing an anti-inflammatory response and contributing to the host’s overall health. The main mechanisms by which probiotic microorganisms can interact with the host are by modulating the immune system and the epithelial cell functions and interacting with intestinal gut microbiota.
      To date, hundreds of different microorganisms are used for the formulation of numerous probiotic products; therefore, it is very difficult to choose the best probiotic product for specific or more general needs. Therefore, physicians are getting more and more confused due to the high number of commercial products which are often lacking healthy effects on the host. Therefore, the aim of this paper is to demonstrate the main characteristics that probiotic microorganisms and products should possess to have a positive impact on the host’s health. To this purpose, this review suggests “10 golden rules” or “commandments” that clinicians should follow to properly select the optimal probiotic product and avoid misidentifications, mislabelling and “pie in the sky” stories.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sonal Sekhar M.
        • Unnikrishnan M.K.
        • Vijayanarayana K.
        • Rodrigues G.S.
        • Mukhopadhyay C.
        Topical application/formulation of probiotics: will it be a novel treatment approach for diabetic foot ulcer?.
        Med Hypotheses. 2014; 82: 86-88
        • Chong E.S.
        A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.
        World J Microbiol Biotechnol. 2014; 30: 351-374
        • Drago L.
        • Toscano M.
        • De Vecchi E.
        • Piconi S.
        • Iemoli L.
        Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis.
        J Clin Gastroenterol. 2012; 46: S56-S63
        • Drago L.
        • Toscano M.
        • Pigatto P.D.
        Probiotics: immunomodulatory properties in allergy and eczema.
        G Ital Dermatol Venereol. 2013; 48: 505-514
        • Corridoni D.
        • Pastorelli L.
        • Mattioli B.
        • Locovei S.
        • Ishikawa D.
        • Arseneau K.O.
        • et al.
        Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism.
        PLoS One. 2012; 7: e42067
        • Pastorelli L.
        • De Salvo C.
        • Mercado J.R.
        • Vecchi M.
        • Pizarro T.T.
        Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.
        Front Immunol. 2013; 4: 280
        • Chapman C.M.
        • Gibson G.R.
        • Rowland I.
        In vitro evaluation of single- and multi-strain probiotics: inter-species inhibition between probiotic strains, and inhibition of pathogens.
        Anaerobe. 2012; 18: 405-413
        • Eckburg P.B.
        • Bik E.M.
        • Bernstein C.N.
        • Purdom E.
        • Dethlefsen L.
        • Sargent M.
        • et al.
        Diversity of the human intestinal microbial flora.
        Science. 2005; 308: 1635-1638
        • Stappenbeck T.S.
        • Hooper L.V.
        • Gordon J.I.
        Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells.
        Proc Natl Acad Sci U S A. 2002; 99: 15451-15455
        • Bäckhed F.
        • Ding H.
        • Wang T.
        • Hooper L.V.
        • Koh G.Y.
        • Nagy A.
        • et al.
        The gut microbiota as an environmental factor that regulates fat storage.
        Proc Natl Acad Sci U S A. 2004; 101: 15718-15723
        • Sekirov I.
        • Russell S.L.
        • Antunes L.C.
        • Finlay B.B.
        Gut microbiota in health and disease.
        Physiol Rev. 2010; 90: 859-904
        • Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria
        Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria.
        Food and Agriculture Organization of the United Nations, World Health Organization, 2001
        • Reid G.
        Probiotics: definition, scope and mechanisms of action.
        Best Pract Res Clin Gastroenterol. 2016; 30: 17-25
        • Adams C.A.
        The probiotic paradox: live and dead cells are biological response modifiers.
        Nutr Res Rev. 2010; 23: 37-46
        • Sakai Y.
        • Tsukahara T.
        • Bukawa W.
        • Matsubara N.
        • Ushida K.
        Cell preparation of Enterococcus faecalis strain EC-12 prevents vancomycin-resistant enterococci colonization in the cecum of newly hatched chicks.
        Poult Sci. 2006; 85: 273-277
        • Marin M.L.
        • Lee J.H.
        • Ustunol M.Z.
        Differential cytokine production in clonal macrophage and T-cell lines cultured with bifidobacteria.
        J Dairy Sci. 1997; 80: 2713-2720
        • Chuang L.
        • Wu K.G.
        • Pai C.
        • Hsieh P.S.
        • Tsai J.J.
        • Yen J.H.
        • et al.
        Heat-killed cells of lactobacilli skew the immune response toward T helper 1 polarization in mouse splenocytes and dendritic cell-treated T cells.
        J Agric Food Chem. 2007; 55: 11080-11086
        • Pessi T.
        • Sütas Y.
        • Saxelin M.
        • Kallioinen H.
        • Isolauri E.
        Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria.
        Appl Environ Microbiol. 1999; 65: 4725-4728
        • Salinas I.
        • Meseguer J.
        • Esteban Á.
        Antiproliferative effects and apoptosis induction by probiotic cytoplasmic extracts in fish cell lines.
        Vet Microbiol. 2008; 126: 287-294
        • Miura N.N.
        • Ohno N.
        • Aketagawa J.
        • Tamura H.
        • Tanaka S.
        • Yadomae T.
        Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice.
        FEMS Immunol Med Microbiol. 1996; 13: 51-57
        • Lau S.
        Bacterial lysates in food allergy prevention.
        Curr Opin Allergy Clin Immunol. 2013; 13: 293-295
        • Hong H.A.
        • Duc le H.
        • Cutting S.M.
        The use of bacterial spore formers as probiotics.
        FEMS Microbiol Rev. 2005; 29: 813-835
        • Klaenhammer T.R.
        • Kullen M.J.
        Selection and design of probiotics.
        Int J Food Microbiol. 1999; 50: 45-57
        • Giroux S.
        • Cedergren R.
        Evolution of a tRNA operon in gamma purple bacteria.
        J Bacteriol. 1989; 171: 6446-6454
        • Weese J.S.
        Evaluation of deficiencies in labeling of commercial probiotics.
        Can Vet J. 2003; 44: 982-983
        • Toscano M.
        • de Vecchi E.
        • Rodighiero V.
        • Drago L.
        Microbiological and genetic identification of some probiotics proposed for medical use in 2011.
        J Chemother. 2013; 25: 156-161
        • Chapman C.M.
        • Gibson G.R.
        • Rowland I.
        Health benefits of probiotics: are mixtures more effective than single strains?.
        Eur J Nutr. 2011; 50: 1-17
        • Drago L.
        • De Vecchi E.
        • Gabrieli A.
        • De Grandi R.
        • Toscano M.
        Immunomodulatory effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, alone and in combination, on peripheral blood mononuclear cells of allergic asthmatics.
        Allergy Asthma Immunol Res. 2015; 7: 409-413
        • Drago L.
        • Gismondo M.R.
        • Lombardi A.
        • de Haën C.
        • Gozzini L.
        Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin.
        FEMS Microbiol Lett. 1997; 153: 455-463
        • Collado M.C.
        • Isolauri E.
        • Salminen S.
        Specific probiotic strains and their combinations counteract adhesion of Enterobacter sakazakii to intestinal mucus.
        FEMS Microbiol Lett. 2008; 285: 58-64
        • Timmerman H.M.
        • Koning C.J.
        • Mulder L.
        • Rombouts F.M.
        • Beynen A.C.
        Monostrain, multistrain and multispecies probiotics—a comparison of functionality and efficacy.
        Int J Food Microbiol. 2004; 96: 219-233
        • Vitali B.
        • Candela M.
        • Matteuzzi D.
        Quantitative detection of probiotic Bifidobacterium strains in bacterial mixtures by using real-time PCR.
        Syst Appl Microbiol. 2003; 26: 269-276
        • Wong A.
        • Ngu D.Y.
        • Dan L.A.
        • Ooi A.
        • Lim R.L.
        Detection of antibiotic resistance in probiotics of dietary supplements.
        Nutr J. 2015; 14: 95
        • EFSA
        The maintenance of the list of QPS microorganisms intentionally added to food or feed—scientific opinion of the panel on biological hazards.
        EFSA J. 2008; 923: 1-48
        • Toscano M.
        • Peroni D.G.
        • De Vecchi E.
        • Mattina R.
        • PDrago L.
        Microbiological assessment of some powdered infant formulas: from quality to antibiotic resistance evaluation.
        J Food Process Technol. 2013; 4: 12
        • Ventola C.L.
        The antibiotic resistance crisis: part 1: causes and threats.
        Pharm Ther. 2015; 40: 277-283
        • Deege M.P.
        • Paterson D.L.
        Reducing the development of antibiotic resistance in critical care units.
        Curr Pharm Biotechnol. 2011; 12: 2062-2069
        • Drago L.
        • Mattina R.
        • De Vecchi E.
        • Toscano M.
        Phenotypic and genotypic antibiotic resistance in some probiotics proposed for medical use.
        Int J Antimicrob Agents. 2013; 41: 396-397
        • Drago L.
        • De Grandi R.
        • De Vecchi E.
        • Toscano M.
        Antibiotic susceptibility profile of a new Lactobacillus kefiri strain.
        J Glob Antimicrob Resist. 2016; 4: 74-75
        • Collado M.C.
        • Sanz Y.
        Induction of acid resistance in Bifidobacterium: a mechanism for improving desirable traits of potentially probiotic strains.
        J Appl Microbiol. 2007; 103: 1147-1157
        • De Angelis M.
        • Bini L.
        • Pallini V.
        • Cocconcelli P.S.
        • Gobbetti M.
        The acid-stress response in Lactobacillus sanfranciscensis CB1.
        Microbiology. 2001; 147: 1863-1873
        • Jan G.
        • Leverrier P.
        • Pichereau V.
        • Boyaval P.
        Changes in protein synthesis and morphology during acid adaptation of Propionibacterium freudenreichii.
        Appl Environ Microbiol. 2001; 67: 2029-2036
        • Matsumoto M.
        • Ohishi H.
        • Benno Y.
        H+-ATPase activity in Bifidobacterium with special reference to acid tolerance.
        Int J Food Microbiol. 2004; 93: 109-113
        • Amachi S.
        • Ishikawa K.
        • Toyoda S.
        • Kagawa Y.
        • Yokota A.
        • Tomita F.
        Characterization of a mutant of Lactococcus lactis with reduced membrane-bound ATPase activity under acidic conditions.
        Biosci Biotechnol Biochem. 1998; 62: 1574-1580
        • Toscano M.
        • De Vecchi E.
        • Gabrieli A.
        • Drago L.
        Probiotic characteristics and in vitro compatibility of a combination of Bifidobacterium breve M-16 V, Bifidobacterium longum subsp. infantis M-63 and Bifidobacterium longum subsp. longum BB536.
        Ann Microbiol. 2015; 65: 1079-1086
        • Elkins C.A.
        • Savage D.C.
        Identification of genes encoding conjugated bile salt hydrolase and transport in Lactobacillus johnsonii 100-100.
        J Bacteriol. 1998; 180: 4344-4349
        • Elkins C.A.
        • Moser S.A.
        • Savage D.C.
        Genes encoding bile salt hydrolases and conjugated bile salt transporters in Lactobacillus johnsonii 100-100 and other Lactobacillus species.
        Microbiology. 2001; 147: 3403-3412
        • Grill J.P.
        • Manginot-Dürr C.
        • Schneider F.
        Bifidobacteria and probiotic effects: action of Bifidobacterium species on conjugated bile salts.
        Curr Microbiol. 1995; 31: 23-27
        • Grill J.
        • Schneider F.
        • Crociani J.
        • Ballongue J.
        Purification and characterization of conjugated bile salt hydrolase from Bifidobacterium longum BB536.
        Appl Environ Microbiol. 1995; 61: 2577-2582
        • Franz C.M.
        • Specht I.
        • Haberer P.
        • Holzapfel W.H.
        Bile salt hydrolase activity of Enterococci isolated from food: screening and quantitative determination.
        J Food Prot. 2001; 64: 725-729
        • Begley M.
        • Hill C.
        • Gahan C.G.
        Bile salt hydrolase activity in probiotics.
        Appl Environ Microbiol. 2006; 72: 1729-1738
        • Sahadeva R.P.K.
        • Leong S.F.
        • Chua K.H.
        • Tan C.H.
        • Chan H.Y.
        Survival of commercial probiotic strains to pH and bile.
        Int Food Res J. 2001; 18: 1515-1522
        • Jacobsen C.N.
        • Rosenfeldt Nielsen V.
        • Hayford A.E.
        • Møller P.L.
        • Michaelsen K.F.
        • Paerregaard A.
        Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans.
        Appl Environ Microbiol. 1999; 65: 4949-4956
        • Oelschlaeger T.A.
        Mechanisms of probiotic actions—a review.
        Int J Med Microbiol. 2010; 300: 57-62
        • Beikler T.
        • Flemmig T.F.
        Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures.
        Periodontology. 2011; 55: 87-103
        • Gomaa Zakaria E.
        Antimicrobial and anti-adhesive properties of biosurfactant produced by lactobacilli isolates, biofilm formation and aggregation ability.
        J Gen Appl Microbiol. 2013; 59: 425-436
        • Dommels Y.E.
        • Kemperman R.A.
        • Zebregs Y.E.
        • Draaisma R.B.
        • Jol A.
        • Wolvers D.A.
        Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
        Appl Environ Microbiol. 2009; 75: 6198-6204
        • Prilassnig M.
        • Wenisch C.
        • Daxboeck F.
        • Feierl G.
        Are probiotics detectable in human feces after oral uptake by healthy volunteers?.
        Wien Klin Wochenschr. 2007; 119: 456-462
        • Viggiano D.
        • Ianiro G.
        • Vanella G.
        • Bibbò S.
        • Bruno G.
        • Simeone G.
        Gut barrier in health and disease: focus on childhood.
        Eur Rev Med Pharmacol Sci. 2015; 19: 1077-1085
        • Kristensen N.B.
        • Bryrup T.
        • Allin K.H.
        • Trine N.
        • Hansen T.H.
        • Pederson O.
        Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials.
        Genome Med. 2016; 8: 52
        • Mayor S.
        Probiotics have no effect on gut microbiota in healthy people, review suggests.
        BMJ. 2016; 353: i2617
        • Drago L.
        • Toscano M.
        • De Vecchi E.
        • Piconi S.
        • Iemoli E.
        Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis.
        J Clin Gastroenterol. 2012; 46: S56-S63
        • Fuller R.
        • Gibson G.R.
        Modification of the intestinal microflora using probiotics and prebiotics.
        Scand J Gastroenterol. 1997; 32: 28-31
        • Goldin B.R.
        • Gorbach S.L.
        • Saxelin M.
        • Barakat S.
        • Gualtieri L.
        • Salminen S.
        Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.
        Dig Dis Sci. 1992; 37: 121-128
        • Papadimitriou K.
        • Zoumpopoulou G.
        • Foligné B.
        • Alexandraki V.
        • Kazou M.
        • Pot B.
        • et al.
        Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches.
        Front Microbiol. 2015; 6: 58
        • De Groote M.A.
        • Frank D.N.
        • Dowell E.
        • DGlode M.P.
        • Pace N.R.
        Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome.
        Pediatr Infect Dis J. 2005; 24: 278-280
        • Vahabnezhad E.
        • Mochon A.B.
        • Wozniak L.J.
        • Ziring D.A.
        Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis.
        J Clin Gastroenterol. 2013; 47: 437-439
        • Sawh S.C.
        • Deshpande S.
        • Jansen S.
        • Reynaert C.J.
        • Jones P.M.
        Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis.
        PeerJ. 2016; 4: e2429
        • Sullivan S.
        • Schanler R.J.
        • Kim J.H.
        • Patel A.L.
        • Trawöger R.
        • Kiechl-Kohlendorfer U.
        • et al.
        An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products.
        J Pediatr. 2010; 156: 562-567
        • Meinzen-Derr J.
        • Poindexter B.
        • Wrage L.
        • Morrow A.L.
        • Stoll B.
        • Donovan E.F.
        Role of human milk in extremely low birth weight infants’ risk of necrotizing enterocolitis or death.
        J Perinatol. 2009; 29: 57-62
        • Zhang Q.
        • Wu Y.
        • Fei X.
        Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
        Medicina (Kaunas). 2016; 52: 28-34
        • Ma Y.Y.
        • Li L.
        • Yu C.H.
        • Shen Z.
        • Chen L.H.
        • Li Y.M.
        Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
        World J Gastroenterol. 2013; 19: 6911-6918
        • Nikbakht E.
        • Khalesi S.
        • Singh I.
        • Williams L.T.
        • West N.P.
        • Colson N.
        Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials.
        Eur J Nutr. 2016;
        • Niccoli A.A.
        • Artesi A.L.
        • Candio F.
        • Ceccarelli S.
        • Cozzali R.
        • Ferraro L.
        • et al.
        Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis.
        J Clin Gastroenterol. 2014; 48: S34-S36
        • Manichanh C.
        • Borruel N.
        • Casellas F.
        • Guarner F.
        The gut microbiota in IBD.
        Nat Rev Gastroenterol Hepatol. 2012; 9: 599-608
        • Van Assche G.
        • Dignass A.
        • Bokemeyer B.
        • Danese S.
        • Gionchetti P.
        • Moser G.
        • et al.
        Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
        J Crohns Colitis. 2013; 7: 1-33
        • Gionchetti P.
        • Rizzello F.
        • Venturi A.
        • Brigidi P.
        • Matteuzzi D.
        • Bazzocchi G.
        • et al.
        Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
        Gastroenterology. 2000; 119: 305-309
        • Mimura T.
        • Rizzello F.
        • Helwig U.
        • Poggioli G.
        • Schreiber S.
        Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.
        Gut. 2004; 53: 108-114
        • Li K.Y.
        • Wang J.L.
        • Wei J.P.
        • Gao S.Y.
        • Zhang Y.Y.
        • Wang L.T.
        • et al.
        Fecal microbiota in pouchitis and ulcerative colitis.
        World J Gastroenterol. 2016; 22: 8929-8939
        • Kruis W.
        • Schütz E.
        • Fric P.
        • Fixa B.
        • Judmaier G.
        • Stolte M.
        • et al.
        Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.
        Aliment Pharmacol Ther. 1997; 11: 853-858
        • Rembacken B.J.
        • Snelling A.M.
        • Hawkey P.M.
        • Chalmers D.M.
        • Axon A.T.
        Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.
        Lancet. 1999; 354: 635-639
        • Kruis W.
        • Fric P.
        • Pokrotnieks J.
        • Lukás M.
        • Fixa B.
        • Kascák M.
        • et al.
        Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
        Gut. 2004; 53: 1617-1623
        • Ritchie M.L.
        • Romanuk T.N.
        A meta-analysis of probiotic efficacy for gastrointestinal diseases.
        PLoS One. 2012; 7: e34938
        • Currò D.
        • Ianiro G.
        • Pecere S.
        • Bibbò S.
        • Cammarota G.
        Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.
        Br J Pharmacol. 2017; 174: 1426-1449
        • Scully P.
        • Macsharry J.
        • O’Mahony D.
        • Lyons A.
        • O’Brien F.
        • Murphy S.
        • et al.
        Bifidobacterium infantis suppression of Peyer’s patch MIP-1alpha and MIP-1beta secretion during Salmonella infection correlates with increased local CD4 + CD 25+ T cell numbers.
        Cell Immunol. 2013; 281: 134-140
        • King T.S.
        • Elia M.
        • Hunter J.O.
        Abnormal colonic fermentation in irritable bowel syndrome.
        Lancet. 1998; 352: 1187-1189
        • Horvath A.
        • Dziechciarz P.
        • Szajewska H.
        Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood.
        Aliment Pharmacol Ther. 2011; 33: 1302-1310
        • Tiequn B.
        • Guanqun C.
        • Shuo Z.
        Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis.
        Intern Med. 2015; 54: 243-249